Sensus Healthcare, Inc. (NASDAQ:SRTS) Shares Bought by Renaissance Technologies LLC

Renaissance Technologies LLC increased its position in Sensus Healthcare, Inc. (NASDAQ:SRTS - Free Report) by 34.4% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 391,534 shares of the company's stock after acquiring an additional 100,294 shares during the period. Renaissance Technologies LLC owned approximately 2.39% of Sensus Healthcare worth $2,087,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of the company. Creekmur Asset Management LLC purchased a new position in Sensus Healthcare during the 4th quarter valued at about $83,000. Hillsdale Investment Management Inc. acquired a new stake in Sensus Healthcare during the 1st quarter valued at $155,000. Chapin Davis Inc. purchased a new position in Sensus Healthcare during the second quarter worth $53,000. Acadian Asset Management LLC raised its holdings in shares of Sensus Healthcare by 578.6% in the second quarter. Acadian Asset Management LLC now owns 45,124 shares of the company's stock worth $239,000 after acquiring an additional 38,474 shares during the last quarter. Finally, Sachetta LLC lifted its position in shares of Sensus Healthcare by 12.9% in the second quarter. Sachetta LLC now owns 118,354 shares of the company's stock valued at $631,000 after acquiring an additional 13,544 shares in the last quarter. 25.30% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several brokerages recently weighed in on SRTS. Roth Capital raised shares of Sensus Healthcare to a "strong-buy" rating in a research note on Friday, July 12th. HC Wainwright reissued a "buy" rating and set a $10.00 price target on shares of Sensus Healthcare in a research note on Monday, August 12th.

Sensus Healthcare Stock Performance

Shares of NASDAQ:SRTS traded up $0.19 during trading on Thursday, reaching $6.29. 118,141 shares of the stock were exchanged, compared to its average volume of 298,349. Sensus Healthcare, Inc. has a 12-month low of $1.79 and a 12-month high of $7.18. The firm's 50-day moving average price is $6.19 and its 200 day moving average price is $5.25. The firm has a market cap of $103.11 million, a price-to-earnings ratio of 21.03 and a beta of 1.05.

Sensus Healthcare (NASDAQ:SRTS - Get Free Report) last issued its earnings results on Thursday, August 8th. The company reported $0.10 EPS for the quarter, beating analysts' consensus estimates of $0.03 by $0.07. Sensus Healthcare had a net margin of 18.27% and a return on equity of 13.46%. The business had revenue of $9.24 million for the quarter, compared to the consensus estimate of $7.00 million. During the same quarter last year, the firm posted ($0.02) EPS. As a group, equities research analysts forecast that Sensus Healthcare, Inc. will post 0.36 EPS for the current year.

Sensus Healthcare Company Profile

Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.